1 Introduction to Research & Analysis Reports
1.1 Bone Resorption Inhibitors Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bone Resorption Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Bone Resorption Inhibitors Overall Market Size
2.1 Global Bone Resorption Inhibitors Market Size: 2022 VS 2029
2.2 Global Bone Resorption Inhibitors Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Bone Resorption Inhibitors Players in Global Market
3.2 Top Global Bone Resorption Inhibitors Companies Ranked by Revenue
3.3 Global Bone Resorption Inhibitors Revenue by Companies
3.4 Top 3 and Top 5 Bone Resorption Inhibitors Companies in Global Market, by Revenue in 2022
3.5 Global Companies Bone Resorption Inhibitors Product Type
3.6 Tier 1, Tier 2 and Tier 3 Bone Resorption Inhibitors Players in Global Market
3.6.1 List of Global Tier 1 Bone Resorption Inhibitors Companies
3.6.2 List of Global Tier 2 and Tier 3 Bone Resorption Inhibitors Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Bone Resorption Inhibitors Market Size Markets, 2022 & 2029
4.1.2 Oral
4.1.3 Parenteral
4.2 By Type – Global Bone Resorption Inhibitors Revenue & Forecasts
4.2.1 By Type – Global Bone Resorption Inhibitors Revenue, 2018-2023
4.2.2 By Type – Global Bone Resorption Inhibitors Revenue, 2024-2029
4.2.3 By Type – Global Bone Resorption Inhibitors Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Bone Resorption Inhibitors Market Size, 2022 & 2029
5.1.2 Giant Cell Tumor of Bone
5.1.3 Hypercalcemia
5.1.4 Osteoporosis
5.1.5 Others
5.2 By Application – Global Bone Resorption Inhibitors Revenue & Forecasts
5.2.1 By Application – Global Bone Resorption Inhibitors Revenue, 2018-2023
5.2.2 By Application – Global Bone Resorption Inhibitors Revenue, 2024-2029
5.2.3 By Application – Global Bone Resorption Inhibitors Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Bone Resorption Inhibitors Market Size, 2022 & 2029
6.2 By Region – Global Bone Resorption Inhibitors Revenue & Forecasts
6.2.1 By Region – Global Bone Resorption Inhibitors Revenue, 2018-2023
6.2.2 By Region – Global Bone Resorption Inhibitors Revenue, 2024-2029
6.2.3 By Region – Global Bone Resorption Inhibitors Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Bone Resorption Inhibitors Revenue, 2018-2029
6.3.2 US Bone Resorption Inhibitors Market Size, 2018-2029
6.3.3 Canada Bone Resorption Inhibitors Market Size, 2018-2029
6.3.4 Mexico Bone Resorption Inhibitors Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Bone Resorption Inhibitors Revenue, 2018-2029
6.4.2 Germany Bone Resorption Inhibitors Market Size, 2018-2029
6.4.3 France Bone Resorption Inhibitors Market Size, 2018-2029
6.4.4 U.K. Bone Resorption Inhibitors Market Size, 2018-2029
6.4.5 Italy Bone Resorption Inhibitors Market Size, 2018-2029
6.4.6 Russia Bone Resorption Inhibitors Market Size, 2018-2029
6.4.7 Nordic Countries Bone Resorption Inhibitors Market Size, 2018-2029
6.4.8 Benelux Bone Resorption Inhibitors Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Bone Resorption Inhibitors Revenue, 2018-2029
6.5.2 China Bone Resorption Inhibitors Market Size, 2018-2029
6.5.3 Japan Bone Resorption Inhibitors Market Size, 2018-2029
6.5.4 South Korea Bone Resorption Inhibitors Market Size, 2018-2029
6.5.5 Southeast Asia Bone Resorption Inhibitors Market Size, 2018-2029
6.5.6 India Bone Resorption Inhibitors Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Bone Resorption Inhibitors Revenue, 2018-2029
6.6.2 Brazil Bone Resorption Inhibitors Market Size, 2018-2029
6.6.3 Argentina Bone Resorption Inhibitors Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Bone Resorption Inhibitors Revenue, 2018-2029
6.7.2 Turkey Bone Resorption Inhibitors Market Size, 2018-2029
6.7.3 Israel Bone Resorption Inhibitors Market Size, 2018-2029
6.7.4 Saudi Arabia Bone Resorption Inhibitors Market Size, 2018-2029
6.7.5 UAE Bone Resorption Inhibitors Market Size, 2018-2029
7 Bone Resorption Inhibitors Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Bone Resorption Inhibitors Major Product Offerings
7.1.4 Novartis Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Bone Resorption Inhibitors Major Product Offerings
7.2.4 Pfizer Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Amgen
7.3.1 Amgen Company Summary
7.3.2 Amgen Business Overview
7.3.3 Amgen Bone Resorption Inhibitors Major Product Offerings
7.3.4 Amgen Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.3.5 Amgen Key News & Latest Developments
7.4 Apotex
7.4.1 Apotex Company Summary
7.4.2 Apotex Business Overview
7.4.3 Apotex Bone Resorption Inhibitors Major Product Offerings
7.4.4 Apotex Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.4.5 Apotex Key News & Latest Developments
7.5 Athenex Pharmaceuticl Divison
7.5.1 Athenex Pharmaceuticl Divison Company Summary
7.5.2 Athenex Pharmaceuticl Divison Business Overview
7.5.3 Athenex Pharmaceuticl Divison Bone Resorption Inhibitors Major Product Offerings
7.5.4 Athenex Pharmaceuticl Divison Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.5.5 Athenex Pharmaceuticl Divison Key News & Latest Developments
7.6 BPI Labs
7.6.1 BPI Labs Company Summary
7.6.2 BPI Labs Business Overview
7.6.3 BPI Labs Bone Resorption Inhibitors Major Product Offerings
7.6.4 BPI Labs Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.6.5 BPI Labs Key News & Latest Developments
7.7 Cipla USA
7.7.1 Cipla USA Company Summary
7.7.2 Cipla USA Business Overview
7.7.3 Cipla USA Bone Resorption Inhibitors Major Product Offerings
7.7.4 Cipla USA Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.7.5 Cipla USA Key News & Latest Developments
7.8 Merck
7.8.1 Merck Company Summary
7.8.2 Merck Business Overview
7.8.3 Merck Bone Resorption Inhibitors Major Product Offerings
7.8.4 Merck Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.8.5 Merck Key News & Latest Developments
7.9 Mylan Institutional
7.9.1 Mylan Institutional Company Summary
7.9.2 Mylan Institutional Business Overview
7.9.3 Mylan Institutional Bone Resorption Inhibitors Major Product Offerings
7.9.4 Mylan Institutional Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.9.5 Mylan Institutional Key News & Latest Developments
7.10 Sagent Pharmaceuticals
7.10.1 Sagent Pharmaceuticals Company Summary
7.10.2 Sagent Pharmaceuticals Business Overview
7.10.3 Sagent Pharmaceuticals Bone Resorption Inhibitors Major Product Offerings
7.10.4 Sagent Pharmaceuticals Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.10.5 Sagent Pharmaceuticals Key News & Latest Developments
7.11 Accord Healthcare
7.11.1 Accord Healthcare Company Summary
7.11.2 Accord Healthcare Business Overview
7.11.3 Accord Healthcare Bone Resorption Inhibitors Major Product Offerings
7.11.4 Accord Healthcare Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.11.5 Accord Healthcare Key News & Latest Developments
7.12 Fresenius Kabi
7.12.1 Fresenius Kabi Company Summary
7.12.2 Fresenius Kabi Business Overview
7.12.3 Fresenius Kabi Bone Resorption Inhibitors Major Product Offerings
7.12.4 Fresenius Kabi Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.12.5 Fresenius Kabi Key News & Latest Developments
7.13 Dr. Reddy’s Laboratories
7.13.1 Dr. Reddy’s Laboratories Company Summary
7.13.2 Dr. Reddy’s Laboratories Business Overview
7.13.3 Dr. Reddy’s Laboratories Bone Resorption Inhibitors Major Product Offerings
7.13.4 Dr. Reddy’s Laboratories Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.13.5 Dr. Reddy’s Laboratories Key News & Latest Developments
7.14 Viatris
7.14.1 Viatris Company Summary
7.14.2 Viatris Business Overview
7.14.3 Viatris Bone Resorption Inhibitors Major Product Offerings
7.14.4 Viatris Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.14.5 Viatris Key News & Latest Developments
7.15 Hikma Pharmaceuticals
7.15.1 Hikma Pharmaceuticals Company Summary
7.15.2 Hikma Pharmaceuticals Business Overview
7.15.3 Hikma Pharmaceuticals Bone Resorption Inhibitors Major Product Offerings
7.15.4 Hikma Pharmaceuticals Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.15.5 Hikma Pharmaceuticals Key News & Latest Developments
7.16 Aurobindo Pharma
7.16.1 Aurobindo Pharma Company Summary
7.16.2 Aurobindo Pharma Business Overview
7.16.3 Aurobindo Pharma Bone Resorption Inhibitors Major Product Offerings
7.16.4 Aurobindo Pharma Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.16.5 Aurobindo Pharma Key News & Latest Developments
7.17 Akorn
7.17.1 Akorn Company Summary
7.17.2 Akorn Business Overview
7.17.3 Akorn Bone Resorption Inhibitors Major Product Offerings
7.17.4 Akorn Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.17.5 Akorn Key News & Latest Developments
7.18 Teva Pharmaceuticals
7.18.1 Teva Pharmaceuticals Company Summary
7.18.2 Teva Pharmaceuticals Business Overview
7.18.3 Teva Pharmaceuticals Bone Resorption Inhibitors Major Product Offerings
7.18.4 Teva Pharmaceuticals Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.18.5 Teva Pharmaceuticals Key News & Latest Developments
7.19 Sun Pharma
7.19.1 Sun Pharma Company Summary
7.19.2 Sun Pharma Business Overview
7.19.3 Sun Pharma Bone Resorption Inhibitors Major Product Offerings
7.19.4 Sun Pharma Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.19.5 Sun Pharma Key News & Latest Developments
7.20 Sun Pharmaceutical Industries
7.20.1 Sun Pharmaceutical Industries Company Summary
7.20.2 Sun Pharmaceutical Industries Business Overview
7.20.3 Sun Pharmaceutical Industries Bone Resorption Inhibitors Major Product Offerings
7.20.4 Sun Pharmaceutical Industries Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.20.5 Sun Pharmaceutical Industries Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
世界の骨吸収阻害剤市場予測2023-2029：経口式、非経口式 |
| 【英語タイトル】Bone Resorption Inhibitors Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5140 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：114 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医療機器＆消耗品 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の骨吸収阻害剤市場規模と予測を収録しています。・世界の骨吸収阻害剤市場：売上、2018年-2023年、2024年-2029年 ・世界の骨吸収阻害剤市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の骨吸収阻害剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「経口式」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 骨吸収阻害剤のグローバル主要企業は、Novartis、 Pfizer、 Amgen、 Apotex、 Athenex Pharmaceuticl Divison、 BPI Labs、 Cipla USA、 Merck、 Mylan Institutional、 Sagent Pharmaceuticals、 Accord Healthcare、 Fresenius Kabi、 Dr. Reddy's Laboratories、 Viatris、 Hikma Pharmaceuticals、 Aurobindo Pharma、 Akorn、 Teva Pharmaceuticals、 Sun Pharma、 Sun Pharmaceutical Industriesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、骨吸収阻害剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の骨吸収阻害剤市場：タイプ別、2018年-2023年、2024年-2029年 世界の骨吸収阻害剤市場：タイプ別市場シェア、2022年 ・経口式、非経口式 世界の骨吸収阻害剤市場：用途別、2018年-2023年、2024年-2029年 世界の骨吸収阻害剤市場：用途別市場シェア、2022年 ・骨巨細胞腫、高カルシウム血症、骨粗鬆症、その他 世界の骨吸収阻害剤市場：地域・国別、2018年-2023年、2024年-2029年 世界の骨吸収阻害剤市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における骨吸収阻害剤のグローバル売上、2018年-2023年 ・主要企業における骨吸収阻害剤のグローバル売上シェア、2022年 ・主要企業における骨吸収阻害剤のグローバル販売量、2018年-2023年 ・主要企業における骨吸収阻害剤のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Novartis、 Pfizer、 Amgen、 Apotex、 Athenex Pharmaceuticl Divison、 BPI Labs、 Cipla USA、 Merck、 Mylan Institutional、 Sagent Pharmaceuticals、 Accord Healthcare、 Fresenius Kabi、 Dr. Reddy's Laboratories、 Viatris、 Hikma Pharmaceuticals、 Aurobindo Pharma、 Akorn、 Teva Pharmaceuticals、 Sun Pharma、 Sun Pharmaceutical Industries ************************************************************* ・調査・分析レポートの概要 骨吸収阻害剤市場の定義 市場セグメント 世界の骨吸収阻害剤市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の骨吸収阻害剤市場規模 世界の骨吸収阻害剤市場規模：2022年 VS 2029年 世界の骨吸収阻害剤市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの骨吸収阻害剤の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の骨吸収阻害剤製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：経口式、非経口式 骨吸収阻害剤のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：骨巨細胞腫、高カルシウム血症、骨粗鬆症、その他 骨吸収阻害剤の用途別グローバル売上・予測 ・地域別市場分析 地域別骨吸収阻害剤市場規模 2022年と2029年 地域別骨吸収阻害剤売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Novartis、 Pfizer、 Amgen、 Apotex、 Athenex Pharmaceuticl Divison、 BPI Labs、 Cipla USA、 Merck、 Mylan Institutional、 Sagent Pharmaceuticals、 Accord Healthcare、 Fresenius Kabi、 Dr. Reddy's Laboratories、 Viatris、 Hikma Pharmaceuticals、 Aurobindo Pharma、 Akorn、 Teva Pharmaceuticals、 Sun Pharma、 Sun Pharmaceutical Industries ... |
This report aims to provide a comprehensive presentation of the global market for Bone Resorption Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bone Resorption Inhibitors. This report contains market size and forecasts of Bone Resorption Inhibitors in global, including the following market information:
Global Bone Resorption Inhibitors Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Bone Resorption Inhibitors market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Oral Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Bone Resorption Inhibitors include Novartis, Pfizer, Amgen, Apotex, Athenex Pharmaceuticl Divison, BPI Labs, Cipla USA, Merck and Mylan Institutional, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bone Resorption Inhibitors companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bone Resorption Inhibitors Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Bone Resorption Inhibitors Market Segment Percentages, by Type, 2022 (%)
Oral
Parenteral
Global Bone Resorption Inhibitors Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Bone Resorption Inhibitors Market Segment Percentages, by Application, 2022 (%)
Giant Cell Tumor of Bone
Hypercalcemia
Osteoporosis
Others
Global Bone Resorption Inhibitors Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Bone Resorption Inhibitors Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bone Resorption Inhibitors revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Bone Resorption Inhibitors revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Pfizer
Amgen
Apotex
Athenex Pharmaceuticl Divison
BPI Labs
Cipla USA
Merck
Mylan Institutional
Sagent Pharmaceuticals
Accord Healthcare
Fresenius Kabi
Dr. Reddy’s Laboratories
Viatris
Hikma Pharmaceuticals
Aurobindo Pharma
Akorn
Teva Pharmaceuticals
Sun Pharma
Sun Pharmaceutical Industries
Outline of Major Chapters:
Chapter 1: Introduces the definition of Bone Resorption Inhibitors, market overview.
Chapter 2: Global Bone Resorption Inhibitors market size in revenue.
Chapter 3: Detailed analysis of Bone Resorption Inhibitors company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bone Resorption Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の骨吸収阻害剤市場予測2023-2029：経口式、非経口式] (コード：MMG23JU5140)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の骨吸収阻害剤市場予測2023-2029：経口式、非経口式]についてメールでお問い合わせ |
